Neuroscience
Major Depressive Disorder
100%
Depression
54%
Anxiety Disorder
53%
Antidepressant
31%
Somatics
27%
Mood Disorder
21%
Physical Dependence
19%
Treatment of Depression
18%
Treatment-Resistant Depression
18%
Bipolar Disorder
18%
Attention Deficit Hyperactivity Disorder
17%
Ketamine
16%
Late Life Depression
16%
Mental Disorder
15%
Meta-Analysis
14%
Psychodynamics
13%
Psychiatry
13%
Depression
11%
C-Reactive Protein
10%
Generalized Anxiety Disorder
10%
Esketamine
9%
Randomized Controlled Trial
9%
Cognitive Behavioral Therapy
9%
Electroconvulsive Therapy
9%
Actigraphy
8%
Psychotomimetic
8%
Dementia Praecox
7%
Personality Disorder
7%
Psychosis
7%
Dysthymia
7%
Hamilton Rating Scale for Depression
6%
Interleukin 6
6%
Longitudinal Study
5%
Neuroticism
5%
Body Mass Index
5%
Adult Attention Deficit Hyperactivity Disorder
5%
Emergency Psychiatry
5%
Chronic Depression
5%
Obsessive-Compulsive Disorder
5%
Tryptophan
5%
Keyphrases
Major Depressive Disorder
58%
Anxiety Disorders
34%
Netherlands
23%
Treatment-resistant Depression
22%
Depressive Disorder
21%
Depressive Symptoms
18%
Ketamine
17%
Depression Treatment
13%
Antidepressants
13%
Bipolar Disorder
11%
Depression Severity
11%
Pharmacotherapy
10%
Psychiatric Disorders
10%
Anxiety Symptoms
10%
Psychotherapy
10%
Mood Disorders
9%
Anxiety-depression
9%
Depressed Patients
8%
Attention Deficit Hyperactivity Disorder
8%
Substance Use Disorder
7%
Meta-analysis
7%
Treatment Outcome
7%
Psychedelics
7%
Electroconvulsive Therapy
6%
Late-life Depression
6%
Depression Course
6%
Life Events
6%
Comorbid
6%
Depressive
6%
Risk Factors
6%
Odds Ratio
5%
DSM-IV
5%
Depression Risk
5%
Inflammatory Markers
5%
Confidence Interval
5%
Psychiatry
5%
Combined Therapy
5%
Somatic Symptoms
5%
Symptom Severity
5%
Psilocybin
5%
C-reactive Protein
5%
Remission
5%
Social Functioning
5%
Supportive Psychotherapy
5%
Medicine and Dentistry
Major Depressive Episode
30%
Depression
26%
Symptom
24%
Randomized Controlled Trial
18%
Treatment Resistant Depression
17%
Systematic Review
17%
Outpatient
16%
Ketamine
15%
Disease
14%
Substance Use Disorder
13%
Drug Therapy
13%
Attention Deficit Disorder
12%
Late Life Depression
11%
Antidepressant
10%
Meta-Analysis
9%
Esketamine
8%
Prevalence
8%
Diagnosis
8%
Health Care Cost
8%
Mental Health
7%
Metabolic Syndrome
7%
Psilocybine
7%
Anxiety Disorder
6%
Psychiatry
6%
Cost-Effectiveness Analysis
6%
Lifestyle Intervention
6%
Mood Disorder
6%
Self Report
5%
Symptomatology
5%
DSM-IV
5%
Severe Mental Illness
5%
Side Effect
5%
Somatics
5%
Combination Therapy
5%